Skip to main content
. 2019 Apr 3;92(1097):20190089. doi: 10.1259/bjr.20190089

Table 4.

DVH metrics of OARs in different plans among all 17 patients

Bladder Rectum Uretha
D2cc(%) V75(cc) D2cc(%) V75(cc) V125(cc)
I a 8.68 ± 1.06 0.48 ± 0.46 8.00 ± 1.01 0.19 ± 0.28 0.00 ± 0.01
II 8.67 ± 0.96 0.51 ± 0.34 8.24 ± 1.05 0.28 ± 0.34 0.03 ± 0.03
III 8.56 ± 0.97 0.46 ± 0.41 8.31 ± 1.09 0.31 ± 0.35 0.02 ± 0.02
P-values
I vs II 0.758 0.796 0.039 0.168 0.001
I vs III 0.423 0.679 0.016 0.094 0.003
II vs III 0.756 0.421 0.918 0.998 0.856
a

I, II and III are “Original”, “Original Boost” and “Additional Boost” plans, respectively.